Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
gastroenterology & hepatology (7) 7
helicobacter pylori (6) 6
gastric cancer (4) 4
helicobacter infections (4) 4
infection (4) 4
microbiology (4) 4
analysis (3) 3
anti-bacterial agents - therapeutic use (3) 3
association (3) 3
cancer (3) 3
eradication (3) 3
helicobacter infections - drug therapy (3) 3
helicobacter pylori - pathogenicity (3) 3
prevention (3) 3
article (2) 2
colorectal cancer (2) 2
development and progression (2) 2
diagnosis (2) 2
female (2) 2
gastritis (2) 2
gastritis - pathology (2) 2
gastrointestinal microbiome - drug effects (2) 2
gastrointestinal neoplasms - epidemiology (2) 2
gastrointestinal neoplasms - etiology (2) 2
gut microbiota (2) 2
helicobacter infections - complications (2) 2
helicobacter infections - epidemiology (2) 2
helicobacter infections - microbiology (2) 2
helicobacter infections - pathology (2) 2
helicobacter infections - prevention & control (2) 2
hepatic encephalopathy - drug therapy (2) 2
lactulose - therapeutic use (2) 2
male (2) 2
management (2) 2
metaanalysis (2) 2
minimal hepatic encephalopathy (2) 2
pancreatic cancer (2) 2
patients (2) 2
research (2) 2
rifamycins - therapeutic use (2) 2
rifaximin (2) 2
risk-factors (2) 2
stomach cancer (2) 2
stomach neoplasms - microbiology (2) 2
stomach neoplasms - prevention & control (2) 2
time factors (2) 2
abridged index medicus (1) 1
adenocarcinoma (1) 1
adult (1) 1
aged (1) 1
algorithms (1) 1
anti-infective agents - adverse effects (1) 1
anti-infective agents - therapeutic use (1) 1
antibodies (1) 1
aspirin (1) 1
atrophic gastritis (1) 1
bacteria (1) 1
bacterial community (1) 1
barretts-esophagus (1) 1
biomarker (1) 1
biopsy (1) 1
breast (1) 1
breast cancer (1) 1
cancer therapies (1) 1
carcinoma (1) 1
care and treatment (1) 1
chemotherapy (1) 1
cirrhosis (1) 1
cisplatin (1) 1
clinical protocols (1) 1
clinical trials (1) 1
cohort studies (1) 1
colon (1) 1
comparing rifaximin (1) 1
complications (1) 1
consensus report (1) 1
data bases (1) 1
databases (1) 1
diversity (1) 1
double-blind (1) 1
drug therapy, combination (1) 1
drug therapy, combination - methods (1) 1
duodenal biopsies (1) 1
duodenum - drug effects (1) 1
duodenum - microbiology (1) 1
dyspepsia (1) 1
dyspepsia - drug therapy (1) 1
dyspepsia - epidemiology (1) 1
dyspepsia - pathology (1) 1
electroencephalography (1) 1
endoscopes (1) 1
endoscopic resection (1) 1
endoscopy (1) 1
endoscopy, gastrointestinal (1) 1
epidemiology (1) 1
epirubicin (1) 1
esophageal (1) 1
esophageal cancer (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Gastric cancer: epidemiology, prevention, and therapy
by Venerito, Marino and Vasapolli, Riccardo and Rokkas, Theodoros and Malfertheiner, Peter
Helicobacter, ISSN 1083-4389, 09/2018, Volume 23, Issue S1, pp. e12518 - n/a
Gastric cancer (GC) is still the third leading cause of cancer death in both sexes worldwide. Helicobacter pylori infection is the most important risk factor... 
MICROBIOLOGY | CISPLATIN | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Humans | Risk Factors | Helicobacter Infections - epidemiology | Helicobacter Infections - prevention & control | Helicobacter pylori - pathogenicity | Male | Stomach Neoplasms - drug therapy | Stomach Neoplasms - microbiology | Helicobacter Infections - drug therapy | Stomach Neoplasms - prevention & control | Female | Stomach Neoplasms - epidemiology | Helicobacter Infections - microbiology | Prevention | Helicobacter infections | Stomach cancer | Epidemiology | Cancer | Health care | Therapy | Aspirin | Territory | Serology | Infections | Risk analysis | Patients | Cisplatin | Data bases | Risk factors | Gastritis | Incidence | Databases | Oxaliplatin | Endoscopes | Helicobacter pylori | Epirubicin | Endoscopy | Gastric cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Helicobacter pylori and non‐malignant upper gastrointestinal diseases
by Vasapolli, Riccardo and Malfertheiner, Peter and Kandulski, Arne
Helicobacter, ISSN 1083-4389, 09/2016, Volume 21, Issue S1, pp. 30 - 33
Peptic ulcer disease (PUD) has been further decreased over the last decades along with decreasing prevalence of Helicobacter pylori‐associated PUD. A delayed... 
Helicobacter pylori | gastro‐esophageal reflux disease | peptic ulcer | dyspepsia | gastro-esophageal reflux disease | IDIOPATHIC PEPTIC-ULCERS | METAANALYSIS | MICROBIOLOGY | BARRETTS-ESOPHAGUS | PREVALENCE | TIME TRENDS | CONSENSUS REPORT | FUNCTIONAL DYSPEPSIA | GASTROESOPHAGEAL-REFLUX DISEASE | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Gastritis - drug therapy | Dyspepsia - drug therapy | Prevalence | Gastroesophageal Reflux - pathology | Humans | Helicobacter Infections - epidemiology | Dyspepsia - pathology | Gastroesophageal Reflux - epidemiology | Peptic Ulcer - epidemiology | Helicobacter Infections - pathology | Esophagitis - pathology | Peptic Ulcer - pathology | Gastritis - epidemiology | Drug Therapy, Combination - methods | Dyspepsia - epidemiology | Gastritis - pathology | Esophagitis - epidemiology | Helicobacter Infections - drug therapy | Esophagitis - drug therapy | Gastroesophageal Reflux - drug therapy | Peptic Ulcer - drug therapy | Gastroesophageal reflux | Helicobacter infections | Gastrointestinal diseases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Helicobacter pylori, gastric cancer and other gastrointestinal malignancies
by Venerito, Marino and Vasapolli, Riccardo and Rokkas, Theodore and Delchier, Jean‐Charles and Malfertheiner, Peter
Helicobacter, ISSN 1083-4389, 09/2017, Volume 22, Issue S1, pp. e12413 - n/a
In a retrospective study performed in California, U.S.A., ca. 3% of patients with gastric intestinal metaplasia (GIM) developed gastric cancer (GC) within a... 
gastric MALT lymphoma | pancreatic cancer | colorectal cancer | esophageal cancer | biomarker | prevention | ANTIBODIES | MICROBIOLOGY | MICRORNAS | ATROPHIC GASTRITIS | H. PYLORI | LYMPHOMA | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | INDEPENDENT RISK-FACTOR | Helicobacter Infections - complications | Gastrointestinal Neoplasms - microbiology | Gastrointestinal Neoplasms - epidemiology | Humans | Helicobacter pylori - pathogenicity | Gastrointestinal Neoplasms - etiology | Helicobacter pylori | Analysis | Pancreatic cancer | Oncology, Experimental | Colorectal cancer | Development and progression | Helicobacter infections | Non-Hodgkin's lymphomas | Research | Stomach cancer | Cancer | Liver | Mucosa | Gastric mucosa | Risk | Population studies | Malignancy | Cancer therapies | Neoplasms | Lymph nodes | Metastases | Mucosal-associated lymphoid tissue | Intestine | Malt | Colon | Gastric cancer | Squamous cell carcinoma | Liver diseases | Health risks | Breast cancer | Regression analysis | Patients | Lymphoma | Esophagus | Metaplasia | Chemotherapy | Biopsy | Breast | Health risk assessment | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Helicobacter pylori and Gastrointestinal Malignancies
by Venerito, Marino and Vasapolli, Riccardo and Rokkas, Theodoros and Malfertheiner, Peter
Helicobacter, ISSN 1083-4389, 09/2015, Volume 20, Issue S1, pp. 36 - 39
Helicobacter pylori infection is the principal trigger of gastric carcinogenesis and gastric cancer (GC) and remains the third leading cause of cancer‐related... 
prevention strategies | screening | pancreatic cancer | colorectal cancer | gastric cancer | hepatobiliary malignancies | Screening | Prevention strategies | Gastric cancer | Pancreatic cancer | Colorectal cancer | Hepatobiliary malignancies | RISK-FACTORS | GASTRIC-CANCER | MICROBIOLOGY | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | Anti-Bacterial Agents - therapeutic use | Gastrointestinal Neoplasms - epidemiology | Risk Assessment | Helicobacter Infections - drug therapy | Humans | Helicobacter pylori - pathogenicity | Helicobacter Infections - complications | Gastrointestinal Neoplasms - etiology | Urea | Helicobacter pylori | Analysis | Helicobacter infections | Diagnosis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Helicobacter pyloriand non-malignant upper gastrointestinal diseases
by Vasapolli, Riccardo and Malfertheiner, Peter and Kandulski, Arne
Helicobacter, ISSN 1083-4389, 09/2016, Volume 21, pp. 30 - 33
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Su1950 - Distinct Microbiota Communities Along the Entire Human Digestive Tract
by Vasapolli, Riccardo and Schuette, Kerstin and Schulz, Christian and Vilchez-Vargas, Ramiro and Malfertheiner, Peter
Gastroenterology, ISSN 0016-5085, 05/2018, Volume 154, Issue 6, pp. S-643 - S-644
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Helicobacter pylori and gastric cancer: Timing and impact of preventive measures
by Venerito, Marino and Vasapolli, Riccardo and Malfertheiner, Peter
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 08/2016, Volume 908, pp. 409 - 418
Helicobacter pylori (H. pylori) is a Gram negative spiraliform bacterium that is commonly found in the stomach. H. pylori infection is still one of the world's... 
SEROPOSITIVITY | RISK-FACTORS | METAANALYSIS | ONCOLOGY | ENDOSCOPIC RESECTION | ADENOCARCINOMA | INFECTION | ERADICATION | ESOPHAGEAL | GASTROENTEROLOGY & HEPATOLOGY | ASSOCIATION | CARCINOMA | Intestines - pathology | Humans | Helicobacter Infections - prevention & control | Helicobacter pylori - drug effects | Stomach Neoplasms - pathology | Host-Pathogen Interactions - drug effects | Gastritis - prevention & control | Helicobacter Infections - pathology | Lymphoma, Non-Hodgkin - pathology | Stomach Neoplasms - microbiology | Anti-Bacterial Agents - therapeutic use | Intestines - microbiology | Gastritis - pathology | Lymphoma, Non-Hodgkin - prevention & control | Stomach Neoplasms - prevention & control | Lymphoma, Non-Hodgkin - microbiology | Gastritis - microbiology | Helicobacter pylori - physiology | Metaplasia - prevention & control | Helicobacter Infections - microbiology
Journal Article
Details down arrow
8. Full Text Sa1922 – Distinct Shifts in Gut Microbiota Composition Throughout the Gastrointestinal Tract During Healthy Aging
by Schütte, Kerstin and Schulz, Christian and Vasapolli, Riccardo and Palm, Frederike and Simon, Bianca and Schomburg, Dirk and Lux, Anke and Link, Alexander and Pieper, Dietmar and Vilchez-Vargas, Ramiro and Malfertheiner, Peter
Gastroenterology, ISSN 0016-5085, 05/2019, Volume 156, Issue 6, pp. S-454 - S-454
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Analysis of Transcriptionally Active Bacteria Throughout the Gastrointestinal Tract of Healthy Individuals
by Vasapolli, Riccardo and Schütte, Kerstin and Schulz, Christian and Vital, Marius and Schomburg, Dirk and Pieper, Dietmar H and Vilchez-Vargas, Ramiro and Malfertheiner, Peter
Gastroenterology, ISSN 0016-5085, 10/2019, Volume 157, Issue 4, pp. 1081 - 1092.e3
The microbiome varies along the human gastrointestinal (GI) tract with exposure to luminal and mucosal factors. We analyzed active bacterial communities at 8... 
Bacterial Community | Mucosal Microbiome | Helicobacter pylori | Gut Microbiota | GASTRITIS | MICROBIOME | REPRODUCIBILITY | RELATIVE VALIDITY | DIVERSITY | GENERATION | GERMAN PART | GASTROENTEROLOGY & HEPATOLOGY | FOOD | Algorithms | Microbiota (Symbiotic organisms) | Ribosomal RNA | Analysis | Gastrointestinal system | Bacteria | Genetic transcription
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prevention, early diagnosis and therapy of gastric cancer
by Venerito, Marino and Vasapolli, Riccardo and Malfertheiner, Peter
MMW-Fortschritte der Medizin, ISSN 1438-3276, 07/2016, Volume 158, Issue 13, pp. 39 - 43
treatment | Helicobacter pylori | eradication | diagnosis | Gastric cancer | prevention
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Helicobacter pyloriand Gastrointestinal Malignancies
by Venerito, Marino and Vasapolli, Riccardo and Rokkas, Theodoros and Malfertheiner, Peter
Helicobacter, ISSN 1083-4389, 09/2015, Volume 20, pp. 36 - 39
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Prevention, early diagnosis and therapy of gastric cancer
by Venerito, Marino and Vasapolli, Riccardo and Malfertheiner, Peter
MMW Fortschritte der Medizin, ISSN 1438-3276, 07/2016, Volume 158, Issue 13, p. 39
Stomach Neoplasms - diagnosis | Humans | Stomach Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Magenkarzinom: Risikopatienten identifizieren und Schlimmeres verhindern
by Venerito, Marino and Vasapolli, Riccardo and Malfertheiner, Peter
MMW - Fortschritte der Medizin, ISSN 1438-3276, 07/2016, Volume 158, Issue 13, pp. 39 - 43
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy
by Schulz, Christian and Schütte, Kerstin and Vilchez-Vargas, Ramiro and Vasapolli, Riccardo and Malfertheiner, Peter
Digestive Diseases, ISSN 0257-2753, 01/2019, Volume 37, Issue 2, pp. 161 - 169
Background: Gut microbiota play an essential role in the pathogenesis of hepatic encephalopathy (HE). Treatment strategies are directed to modulate intestinal... 
Microbiota: Original Paper | Duodenal biopsies | Minimal hepatic encephalopathy | Rifaximin | Gut microbiota function | Faeces | Gut microbiota composition | MANAGEMENT | GUT MICROBIOTA | LIVER-DISEASE | ARTICLE | PROFILE | CIRRHOSIS | POTENTIAL MECHANISMS | COMPLICATIONS | GASTROENTEROLOGY & HEPATOLOGY | MODULATION | Intestine, Small - pathology | Humans | Middle Aged | Male | Phylogeny | Hepatic Encephalopathy - drug therapy | Rifaximin - therapeutic use | Anti-Bacterial Agents - therapeutic use | Feces - microbiology | Gastrointestinal Microbiome - drug effects | Rifamycins - therapeutic use | Time Factors | Hepatic Encephalopathy - microbiology | Intestine, Small - drug effects | Adult | Female | Aged | Lactulose - therapeutic use | Rifaximin - pharmacology | Lactulose - pharmacology | Principal Component Analysis | Cohort Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: Study protocol for a randomized controlled trial
by Schulz, Christian and Schütte, Kerstin and Kropf, Siegfried and Schmitt, Friedhelm C and Vasapolli, Riccardo and Kliegis, Leon M and Riegger, Antonia and Malfertheiner, Peter
Trials, ISSN 1745-6215, 02/2016, Volume 17, Issue 1, p. 111
Background: Hepatic encephalopathy (HE) is a clinically significant complication of liver cirrhosis impacting on the patients' quality of life. Minimal hepatic... 
Minimal hepatic encephalopathy | Rifaximin | Liver cirrhosis | Hepatic encephalopathy | MEDICINE, RESEARCH & EXPERIMENTAL | ARTICLE | LACTULOSE | MANAGEMENT | DOUBLE-BLIND | QUALITY-OF-LIFE | COMPARING RIFAXIMIN | Humans | Clinical Protocols | Electroencephalography | Hepatic Encephalopathy - drug therapy | Duodenum - microbiology | Rifamycins - therapeutic use | Time Factors | Rifamycins - adverse effects | Evoked Potentials, Visual | Hepatic Encephalopathy - diagnosis | Lactulose - therapeutic use | Drug Therapy, Combination | Stomach - drug effects | Liver Cirrhosis - diagnosis | Anti-Infective Agents - adverse effects | Liver Cirrhosis - complications | Anti-Infective Agents - therapeutic use | Endoscopy, Gastrointestinal | Hepatic Encephalopathy - physiopathology | Psychometrics | Treatment Outcome | Pilot Projects | Gastrointestinal Microbiome - drug effects | Hepatic Encephalopathy - psychology | Research Design | Stomach - microbiology | Germany | Duodenum - drug effects | Flicker Fusion | Usage | Care and treatment | Patient outcomes | Clinical trials | Development and progression | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.